The popularity of Viagra initially fueled a surge for pharma, however recent shifts present a uncertain scenario for shareholders. Generic alternatives are reducing earnings, and ongoing litigation add more difficulty https://deborahropx282752.bcbloggers.com/39985599/sildenafil-and-pharma-a-risky-bet